MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., its President and Chief Executive Officer, and Fritz L. LaPorte, its Senior Vice President and Chief Financial Officer, are scheduled to present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008, at 3:55 p.m. The conference will be held at the Grand Hyatt New York.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets its advanced robotic-arm solution and implants for minimally invasive orthopedic knee procedures. The MAKO Tactile Guidance System(tm) (TGS(tm)) is a surgeon-interactive tactile platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee joint for the insertion and alignment of resurfacing implants through a minimal incision. This FDA-cleared TGS allows surgeons to provide a tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than 200 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, haptics, robotics and implants. Additional information can be found at www.makosurgical.com.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: MAKO Surgical Corp

MAKO Surgical Corp.
          Investors:
          Susan M. Verde
          954-927-2044 x349
          sverde@makosurgical.com

          Westwicke Partners
          Mark Klausner
          410-321-9650
          mark.klausner@westwickepartners.com